The St. Jude Children's Research Hospital-led national BABY HUG trial linked hydroxyurea to a 21 percent reduction in annual medical costs for young children with sickle cell anemia; savings expected to grow A drug proven effective for treatment of adults and children with sickle cell anemia reduced hospitalizations and cut annual estimated medical ... (more)
http://www.eurekalert.org/pub_releases/2013-09/sjcr-drh082913.php
http://www.eurekalert.org/pub_releases/2013-09/sjcr-drh082913.php
No comments:
Post a Comment